2024-10-24 08:26:31
China's first personalized neoantigen-targeted cancer vaccine receives NMPA's clinical trial approval
Health/ 2023-07-22
China's first personalized neoantig...

BEIJING,March 17,2023-- According the latest data released at the Clinical Trials Implied Approval section on the website of China\'s Center...

Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion
Corporate/ 2023-07-24
Samsung Biologics announces construction...

The company plans to begin construction in the first half of 2023 and commence operations in 2025 As part of Samsung Biologics\' second Bio ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release